Ferring Pharmaceuticals and Karolinska Institutet have signed a collaboration agreement for the establishment of a research center exploiting the human microbiome. Parts of the research will be carried out at SciLifeLab, providing access to a broad technical platform for studying complex microbiological communities in well-defined human material. The programme will be fully funded by Ferring Pharmaceuticals and led by Professor Lars Engstrand, Karolinska Institutet/SciLifeLab whom will serve as director.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.